Patient-Specific Induced Pluripotent Stem-Cell Models for Long-QT Syndrome
Open accessThe DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Long-QT syndromes are heritable diseases associated with prolongation of the QT interval on an electrocardiogram and a high risk of sudden cardiac death due to ventricular tachyarrhythmia. In long-QT syndrome type 1, mutations occur in the KCNQ1 gene, which encodes the repolarizing potassium channel mediating the delayed rectifier I(Ks) current. METHODS: We screened a family affected by long-QT syndrome type 1 and identified an autosomal dominant missense mutation (R190Q) in the KCNQ1 gene. We obtained dermal fibroblasts from two family members and two healthy controls and infected them with retroviral vectors encoding the human transcription factors OCT3/4, SOX2, KLF4, and c-MYC to generate pluripotent stem cells. With the use of a specific protocol, these cells were then directed to differentiate into cardiac myocytes. RESULTS: Induced pluripotent stem cells maintained the disease genotype of long-QT syndrome type 1 and generated functional myocytes. Individual cells showed a “ventricular,” “atrial,” or “nodal” phenotype, as evidenced by the expression of cell-type–specific markers and as seen in recordings of the action potentials in single cells. The duration of the action potential was markedly prolonged in “ventricular” and “atrial” cells derived from patients with long-QT syndrome type 1, as compared with cells from control subjects. Further characterization of the role of the R190Q–KCNQ1 mutation in the pathogenesis of long-QT syndrome type 1 revealed a dominant negative trafficking defect associated with a 70 to 80% reduction in I(Ks) current and altered channel activation and deactivation properties. Moreover, we showed that myocytes derived from patients with long-QT syndrome type 1 had an increased susceptibility to catecholamine-induced tachyarrhythmia and that beta-blockade attenuated this phenotype. CONCLUSIONS: We generated patient-specific pluripotent stem cells from members of a family affected by long-QT syndrome type 1 and induced them to differentiate into functional cardiac myocytes. The patient-derived cells recapitulated the electrophysiological features of the disorder. (Funded by the European Research Council and others.)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Ventricle beat rates showed a positive chronotropic response over the concentration range in both the NRVM and hiPSC-CM ventricles (Fig. 3c), as expected for healthy NRVM59, hiPSC-CM60, engineered hiPSC-CM cardiac tissues16, and human patients61.”
From A tissue-engineered scale model of the heart ventricle (2018) · cites this paper as [60]
In the citing paper
“Various cell models built with iPSC derivatives have been shown to resemble in vivo or primary cell counterparts at transcriptional, cellular, and functional levels whilst leaving little interference to the genetic content [4,5,6,7].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [5]
In the citing paper
“Previous studies using iPSC-derived cardiomyocytes from type-1 LQTS patients revealed that the mutation in KCNQ1 caused potassium ion channel dysfunction resulting in sarcolemmal deficiency [5,6].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [5]
In the citing paper
“Tumorous cell lines, although able to proliferate, are often incorporated with unwanted genetic or chromosomal abnormalities, which might induce interference to the resulting outcomes [4,5].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [5]
In the citing paper
“Models built with iPSC derivatives also demonstrate functional and phenotypic traits comparable to their human in vivo parallel [4,5,6].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [5]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Reprogramming of human somatic cells to pluripotency with defined factors
Park, I.-H., Zhao, R., West, J. A., Yabuuchi, A., Huo, H., Ince, T. A., Lerou, P. H., Lensch, M. W., & Daley, G. Q. (2008) · Nature · doi:10.1038/nature06534 · Cited by 2,436
Disease-Specific Induced Pluripotent Stem Cells.
Park, I.-H., Arora, N., Huo, H., Maherali, N., Ahfeldt, T., Shimamura, A., Lensch, M. W., Cowan, C., Hochedlinger, K., & Daley, G. Q. (2008) · Cell · doi:10.1016/j.cell.2008.07.041 · Cited by 2,196
Dimos, J. T., Rodolfa, K. T., Niakan, K. K., Weisenthal, L. M., Mitsumoto, H., Chung, W., Croft, G. F., Saphier, G., Leibel, R., Goland, R., et al. (2008) · Science · doi:10.1126/science.1158799 · Cited by 1,962
Soldner, F., Hockemeyer, D., Beard, C., Gao, Q., Bell, G. W., Cook, E. G., Hargus, G., Blak, A., Cooper, O., Mitalipova, M., et al. (2009) · Cell · doi:10.1016/j.cell.2009.02.013 · Cited by 1,549
Risk Stratification in the Long-QT Syndrome
Priori, S. G., Schwartz, P. J., Napolitano, C., Bloise, R., Ronchetti, E., Grillo, M., Vicentini, A., Spazzolini, C., Nastoli, J., Bottelli, G., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022147 · Cited by 1,459
Induced pluripotent stem cells from a spinal muscular atrophy patient
Ebert, A. D., Yu, J., Rose, F. F., Mattis, V. B., Lorson, C. L., Thomson, J. A., & Svendsen, C. N. (2009) · Nature · doi:10.1038/nature07677 · Cited by 1,441
Stem Cells, the Molecular Circuitry of Pluripotency and Nuclear Reprogramming
Jaenisch, R., & Young, R. (2008) · Cell · doi:10.1016/j.cell.2008.01.015 · Cited by 1,427
Functional Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells
Zhang, J., Wilson, G. F., Soerens, A. G., Koonce, C. H., Yu, J., Palecek, S. P., Thomson, J. A., & Kamp, T. J. (2009) · Circulation Research · doi:10.1161/circresaha.108.192237 · Cited by 1,407
Research works printed but not linked: 2
- Freund C, 2010, Neth Heart J, 18, 51
- Brunner M, 2008, J Clin Invest, 118, 2246
Cited by
Items 701–800 of 1,000
Hudson, J. E., & Zimmermann, W. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.06.011 · Cited by 14
Zhong, L., Yan, Z., Jiang, D., Weng, K., Ouyang, Y., Zhang, H., Lin, X., Xiao, C., Yang, H., Yao, J., et al. (2024) · Circulation Research · doi:10.1161/circresaha.124.325009 · Cited by 14
Vo, Q. D., Nakamura, K., Saito, Y., Akagi, S., Miyoshi, T., & Yuasa, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26114984 · Cited by 13
Multimodal, device-based therapeutic targeting of the cardiovascular autonomic nervous system
Paton, J. F. R., Żera, T., Vadigepalli, R., Herring, N., & Paterson, D. J. (2025) · Nature Reviews Cardiology · doi:10.1038/s41569-025-01212-4 · Cited by 20
Kinnear, C., Agrawal, R., Loo, C. K. J., Pahnke, A., Rodrigues, D. C., Thompson, T., Akinrinade, O., Ahadian, S., Keeley, F. W., Radisic, M., et al. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.119.313936 · Cited by 14
Xu, H., Wali, R., Cheruiyot, C., Bodenschatz, J. F. E., Hasenfuss, G. P., Janshoff, A., Habeck, M., & Ebert, A. (2021) · FEBS Letters · doi:10.1002/1873-3468.14189 · Cited by 14
Current Progress and Potential Practical Application for Human Pluripotent Stem Cells
Philonenko, E. S., Shutova, M. V., Chestkov, I. V., Lagarkova, M. A., & Киселев, С. Л. (2011) · International review of cytology · doi:10.1016/b978-0-12-386033-0.00004-9 · Cited by 14
Systematic approaches to dissect biological processes in stem cells by image‐based screening
Erdmann, G., Volz, C., & Boutros, M. (2012) · Biotechnology Journal · doi:10.1002/biot.201200117 · Cited by 13
Induced pluripotent stem cells as a tool for gaining new insights into Fanconi anemia
Müller, L., Schlaeger, T. M., DeVine, A. L., & Williams, D. A. (2012) · Cell Cycle · doi:10.4161/cc.21109 · Cited by 17
Adrenergic Stress Protection of Human iPS Cell-Derived Cardiomyocytes by Fast Kv7.1 Recycling
Piccini, I., Fehrmann, E., Frank, S., Müller, F. U., Greber, B., & Seebohm, G. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00705 · Cited by 13
Induced Pluripotent Stem Cells and Induced Pluripotent Cancer Cells in Cancer Disease Modeling
Zhu, D., Kong, C. S. L., Gingold, J. A., Zhao, R., & Lee, D. (2018) · Advances in experimental medicine and biology · doi:10.1007/5584_2018_257 · Cited by 14
Elena‐Herrmann, B., Montellier, E., Fages, A., Bruck‐Haimson, R., & Moussaieff, A. (2020) · Scientific Reports · doi:10.1038/s41598-020-58377-w · Cited by 13
Separation of HCM and LQT Cardiac Diseases with Machine Learning of Ca2+ Transient Profiles
Joutsijoki, H., Penttinen, K., Juhola, M., & Aalto‐Setälä, K. (2019) · Methods of Information in Medicine · doi:10.1055/s-0040-1701484 · Cited by 15
Induced Pluripotent Stem Cells in Cardiovascular Research
Sinnecker, D., Dirschinger, R. J., Goedel, A., Moretti, A., Lipp, P., & Laugwitz, K. (2012) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/112_2012_6 · Cited by 13
Self-citationThe proliferation study of hips cell-derived neuronal progenitors on poly-caprolactone scaffold.
Havasi, P., Soleimani, M., Morovvati, H., Bakhshandeh, B., & Nabiuni, M. (2014) · PubMed Central · Cited by 14
New approaches to establish genetic causality
McNally, E. M., & George, A. L. (2015) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2015.02.013 · Cited by 14
Tissue-Engineering for the Study of Cardiac Biomechanics
Ma, S. P., & Vunjak‐Novakovic, G. (2016) · Journal of Biomechanical Engineering · doi:10.1115/1.4032355 · Cited by 15
Many Cells Make Life Work—Multicellularity in Stem Cell-Based Cardiac Disease Modelling
Wang, B., Kit‐Anan, W., & Terracciano, C. M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113361 · Cited by 15
Precision Medicine and Cardiac Channelopathies: Human iPSCs Take the Lead
Sebastian, S. A., Panthangi, V., Sethi, Y., Padda, I., Khan, U., Affas, Z., Mareddy, C., Dolack, L., & Johal, G. (2023) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2023.101990 · Cited by 13
The occurrence and development of induced pluripotent stem cells
Chen, Y., Li, M., & Wu, Y. (2024) · Frontiers in Genetics · doi:10.3389/fgene.2024.1389558 · Cited by 18
Farboud, S. P., Fathi, E., Valipour, B., & Farahzadi, R. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05499-8 · Cited by 18
Perspectives and Challenges of Pluripotent Stem Cells in Cardiac Arrhythmia Research
Goedel, A., My, I., Sinnecker, D., & Moretti, A. (2017) · Current Cardiology Reports · doi:10.1007/s11886-017-0828-z · Cited by 13
Self-citationiPSCs and Exosomes: Partners in Crime Fighting Cardiovascular Diseases
Germena, G., & Hinkel, R. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11060529 · Cited by 13
Investigating inherited arrhythmias using hiPSC-derived cardiomyocytes
Arslanova, A., Shafaattalab, S., Lin, E. C., Barszczewski, T., Hove‐Madsen, L., & Tibbits, G. F. (2021) · Methods · doi:10.1016/j.ymeth.2021.06.015 · Cited by 15
Measuring hypertrophy in neonatal rat primary cardiomyocytes and human iPSC-derived cardiomyocytes
Bourque, K., Hawey, C., Jones-Tabah, J., Pétrin, D., Martin, R., Sun, Y., & Hébert, T. E. (2021) · Methods · doi:10.1016/j.ymeth.2021.12.006 · Cited by 13
Optogenetic Control of Human Induced Pluripotent Stem Cell‐Derived Cardiac Tissue Models
Gruber, A., Edri, O., Glatstein, S., Goldfracht, I., Huber, I., Arbel, G., Gepstein, A., Chorna, S. V., & Gepstein, L. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.021615 · Cited by 16
Microphysiological stem cell models of the human heart
Arslan, U., Moruzzi, A., Nowacka‐Woszuk, J., Mummery, C. L., Eckardt, D., Loskill, P., & Orlova, V. V. (2022) · Materials Today Bio · doi:10.1016/j.mtbio.2022.100259 · Cited by 12
Cellular Reprogramming: A New Technology Frontier in Pharmaceutical Research
Brock, A., Goh, H.-T., Yang, B., Lu, Y., Li, H., & Loh, Y. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0618-z · Cited by 12
Mechanisms underlying diabetic cardiomyopathy: From pathophysiology to novel therapeutic targets.
Cong, S., Ramachandra, C. J. A., Ja, K. P. M. M., Yap, J., SHIM, W. S. N., Wei, L., & Hausenloy, D. J. (2020) · PubMed · Cited by 15
Kelly, M. I., Albahrani, M., Castro, C., Poon, E. N.-Y., Yan, B., Littrell, J., Waas, M., Boheler, K. R., & Gundry, R. L. (2021) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-021-02554-x · Cited by 13
Using human induced pluripotent stem cells to model cerebellar disease: Hope and hype
Wiethoff, S., Arber, C., Li, A., Wray, S., Houlden, H., & Patani, R. (2015) · Journal of Neurogenetics · doi:10.3109/01677063.2015.1053478 · Cited by 11
‘Shovel-Ready’ applications of stem cell advances for pediatric heart disease
Files, M. D., & Boucek, R. J. (2012) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e328357a4cf · Cited by 11
KCNH2 encodes a nuclear-targeted polypeptide that mediates hERG1 channel gating and expression
Jain, A., Stack, O., Ghodrati, S., Sanchez-Conde, F. G., Ukachukwu, C. U., Salwi, S. M., Jiménez‐Vázquez, E. N., & Jones, D. K. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2214700120 · Cited by 11
The impact of genetics on the long QT syndrome: myth or reality?
Schwartz, P. J., & Sala, L. (2023) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000001027 · Cited by 11
Recent advances inin vivoscreening for antiarrhythmic drugs
MacRae, C. A. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.743990 · Cited by 13
Hydrodynamics and bioprocess considerations in designing bioreactors for cardiac tissue engineering
Teo, A., Mantalaris, A., & Lim, M. (2012) · journal of Regenerative Medicine and Tissue Engineering · doi:10.7243/2050-1218-1-4 · Cited by 13
Human Pluripotent Stem Cells for Genetic Disease Modeling and Drug Screening
Gauthier, M., Maury, Y., Peschanski, M., & Martinat, C. (2011) · Regenerative Medicine · doi:10.2217/rme.11.46 · Cited by 11
Šarić, T., Halbach, M., Khalil, M., & Er, F. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.863275 · Cited by 14
Genome-wide association studies and contribution to cardiovascular physiology
Munroe, P. B., & Tinker, A. (2015) · Physiological Genomics · doi:10.1152/physiolgenomics.00004.2015 · Cited by 12
Studying Kidney Disease Using Tissue and Genome Engineering in Human Pluripotent Stem Cells
Garreta, E., Gonzãlez, F., & Montserrat, N. (2017) · The Nephron journals/Nephron journals · doi:10.1159/000480710 · Cited by 13
Investigating pediatric disorders with induced pluripotent stem cells
Durbin, M. D., Cadar, A. G., Chun, Y. W., & Hong, C. C. (2018) · Pediatric Research · doi:10.1038/s41390-018-0064-2 · Cited by 12
Deconvoluting the Cells of the Human Heart with iPSC Technology: Cell Types, Protocols, and Uses
Yu, B., Zhao, S. R., Yan, C. D., Zhang, M., & Wu, J. C. (2022) · Current Cardiology Reports · doi:10.1007/s11886-022-01670-z · Cited by 11
Mohseni, R., Shoae‐Hassani, A., & Verdi, J. (2014) · Cell Biology International · doi:10.1002/cbin.10411 · Cited by 11
Engineering skeletal muscle tissue in bioreactor systems
An, Y., & Li, D. (2014) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.20141076 · Cited by 14
Ramachandra, C. J. A., Mehta, A. K., Lua, C. H., Chitre, A., Ja, K. P. M. M., & SHIM, W. S. N. (2016) · Stem Cells · doi:10.1002/stem.2420 · Cited by 11
Recent advances in animal and human pluripotent stem cell modeling of cardiac laminopathy
Lee, Y.-K., Jiang, Y., Ran, X., Lau, Y., Ng, K., Lai, W., Siu, C., & Tse, H. (2016) · Stem Cell Research & Therapy · doi:10.1186/s13287-016-0401-5 · Cited by 14
Moreau, A., Boutjdir, M., & Chahine, M. (2017) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2016-0726 · Cited by 11
Lieu, D. K., Turnbull, I. C., Costa, K. D., & Li, R. A. (2012) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2012.06.002 · Cited by 12
Induced pluripotent stem cells and regenerative medicine
Chen, Y.-C., Tsai, K.-L., Hung, C.-W., Ding, D., Chen, L.-H., Chang, Y.-L., Chen, L., & Chiou, S. (2011) · Journal of Clinical Gerontology and Geriatrics · doi:10.1016/j.jcgg.2010.12.003 · Cited by 11
Stem cell‐derived cardiomyocyte heterogeneity confounds electrophysiological insights
Clark, A. P., Krogh‐Madsen, T., & Christini, D. J. (2024) · The Journal of Physiology · doi:10.1113/jp284618 · Cited by 12
Harmer, S. C., & Tinker, A. (2016) · Biological Chemistry · doi:10.1515/hsz-2015-0306 · Cited by 10
Carvalho, A. B., Coutinho, K. C. D. S., Barbosa, R. A. Q., de Campos, D. B. P., Leitão, I. D. C., Pinto, R. S., dos Santos, D. S., Farjun, B., Araujo, D. S., Mesquita, F., et al. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.1077069 · Cited by 10
Firas, J., Liu, X., Nefzger, C. M., & Polo, J. M. (2014) · Differentiation · doi:10.1016/j.diff.2014.05.003 · Cited by 10
Bernstein, D., & Burridge, P. W. (2014) · Progress in Pediatric Cardiology · doi:10.1016/j.ppedcard.2014.10.006 · Cited by 12
Is Human-induced Pluripotent Stem Cell the Best Optimal?
Wang, F., Kong, J., Cui, Y., Liu, P., & Wen, J.-Y. (2018) · Chinese Medical Journal · doi:10.4103/0366-6999.228231 · Cited by 11
Electrophysiological Analysis of hiPSC-Derived Cardiomyocytes Using a Patch-Clamp Technique
Yamamoto, Y., Hirose, S., Wuriyanghai, Y., Yoshinaga, D., & Makiyama, T. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1484-6_13 · Cited by 12
Reisqs, J., Moreau, A., Sleiman, Y., Boutjdir, M., Richard, S., & Chevalier, P. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1191965 · Cited by 10
Human Stem Cells for Craniomaxillofacial Reconstruction
Jalali, M., Kirkpatrick, W. N. A., Cameron, M. G., Pauklin, S., & Vallier, L. (2014) · Stem Cells and Development · doi:10.1089/scd.2013.0576 · Cited by 11
iPSC for Dental Tissue Regeneration
Hynes, K., Gronthos, S., & Bartold, P. M. (2014) · Current Oral Health Reports · doi:10.1007/s40496-013-0001-8 · Cited by 10
Modeling Human Protein Aggregation Cardiomyopathy Using Murine Induced Pluripotent Stem Cells
Limphong, P., Zhang, H., Christians, E., Liu, Q., Riedel, M. J., Ivey, K. N., Cheng, P. P., Mitzelfelt, K. A., Taylor, G., Winge, D. R., et al. (2013) · Stem Cells Translational Medicine · doi:10.5966/sctm.2012-0073 · Cited by 10
Uses of cardiomyocytes generated from induced pluripotent stem cells
Lu, T., & Yang, L. (2011) · Stem Cell Research & Therapy · doi:10.1186/scrt85 · Cited by 10
From iPSC towards cardiac tissue—a road under construction
Peischard, S., Piccini, I., Strutz‐Seebohm, N., Greber, B., & Seebohm, G. (2017) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-017-2003-1 · Cited by 12
INDUCED PLURIPOTENT STEM CELLS FOR MODELLING ENERGETIC ALTERATIONS IN HYPERTROPHIC CARDIOMYOPATHY.
Ramachandra, C. J. A., Ja, K. P. M. M., Lin, Y., SHIM, W. S. N., Boisvert, W. A., & Hausenloy, D. J. (2019) · PubMed · Cited by 10
Morpho-functional comparison of differentiation protocols to create iPSC-derived cardiomyocytes
Nijak, A., Simons, E., Vandendriessche, B., de Sande, D. V. V., Fransén, E., Sieliwończyk, E., Gucht, I. V., Craenenbroeck, E. M. V., Saenen, J. B., Heidbüchel, H., et al. (2022) · Biology Open · doi:10.1242/bio.059016 · Cited by 10
Kane, C., & Terracciano, C. M. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.10.023 · Cited by 12
Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons
Qi, S. D., Smith, P. D., & Choong, P. (2012) · ANZ Journal of Surgery · doi:10.1111/j.1445-2197.2012.06282.x · Cited by 9
Luo, Y., Chen, Y., Ge, L., Zhou, G., Chen, Y., & Zhu, D. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03601-3 · Cited by 9
Florido, M. H. C., & Ziats, N. P. (2024) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.37669 · Cited by 9
Cell and tissue reprogramming: Unlocking a new era in medical drug discovery
Sen, C. K., Friday, A. J., & Roy, S. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100077 · Cited by 11
Pluripotent Stem Cells as a Platform for Cardiac Arrhythmia Drug Screening
Leyton-Mange, J. S., & Milan, D. J. (2014) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-014-0334-1 · Cited by 10
Trends in cardiovascular engineering: Organizing the human heart
Tulloch, N. L., & Murry, C. E. (2013) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2013.04.001 · Cited by 10
Yang, X., Gu, J., Yan, H., Xu, Z., Ren, B., Yang, X., Yang, X., Chen, Q., & Tan, S. (2014) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2014.03.005 · Cited by 9
Electrical effects of stem cell transplantation for ischaemic cardiomyopathy: friend or foe?
Mount, S., & Davis, D. R. (2015) · The Journal of Physiology · doi:10.1113/jp270540 · Cited by 11
Induced pluripotent stem cell technology and inherited arrhythmia syndromes
Ross, S. B., Fraser, S. T., & Semsarian, C. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.08.013 · Cited by 10
Winbo, A., Ashton, J. L., & Montgomery, J. M. (2020) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2020.105737 · Cited by 9
On computational classification of genetic cardiac diseases applying iPSC cardiomyocytes
Juhola, M., Joutsijoki, H., Penttinen, K., Shah, D. A., & Aalto‐Setälä, K. (2021) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2021.106367 · Cited by 10
Linn, A. K., Maneepitasut, W., Tubsuwan, A., Kitiyanant, N., Phakdeekitcharoen, B., Borwornpinyo, S., Hongeng, S., & Phanthong, P. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12050766 · Cited by 9
Korover, N., Etzion, S., Cherniak, A., Rabinski, T., Levitas, A., Etzion, Y., Ofir, R., Parvari, R., & Cohen, S. (2023) · Biological Research · doi:10.1186/s40659-023-00442-5 · Cited by 8
Babini, H., Jiménez-Sábado, V., Stogova, E., Arslanova, A., Butt, M., Dababneh, S., Asghari, P., Moore, E. D. W., Claydon, T. W., Chiamvimonvat, N., et al. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1298007 · Cited by 10
Human Genomics in Cardiovascular Medicine: Implications and Perspectives
Morita, H. (2013) · Circulation Journal · doi:10.1253/circj.cj-13-0126 · Cited by 9
Szebényi, K., Erdei, Z., Péntek, A., Sebe, A., Orbán, T. I., Sarkadi, B., & Apáti, Á. (2011) · Personalized Medicine · doi:10.2217/pme.11.19 · Cited by 13
Spätjens, R. L. H. M. G., Bébarová, M., Seyen, S. R. M., Lentink, V., Jongbloed, R. J. E., Arens, Y. H. J. M., Heijman, J., & Volders, P. G. A. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu191 · Cited by 9
iPCS Cell Modeling of Inherited Cardiac Arrhythmias
Shinnawi, R., & Gepstein, L. (2014) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-014-0331-4 · Cited by 11
Expansion of Human Induced Pluripotent Stem Cells in Stirred Suspension Bioreactors
Almutawa, W., Rohani, L., & Rancourt, D. E. (2015) · Methods in molecular biology · doi:10.1007/7651_2015_311 · Cited by 10
Disease modeling of cardiac arrhythmias using human induced pluripotent stem cells
Liang, W., Gasparyan, L., Alqarawi, W., & Davis, D. R. (2019) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2019.1575359 · Cited by 11
Eng, G. M., Lee, B. W., Radisic, M., & Vunjak‐Novakovic, G. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-398358-9.00038-0 · Cited by 14
Zanella, F., & Sheikh, F. (2014) · Methods in molecular biology · doi:10.1007/7651_2014_172 · Cited by 12
Machine learning to differentiate diseased cardiomyocytes from healthy control cells
Juhola, M., Joutsijoki, H., Penttinen, K., & Aalto‐Setälä, K. (2019) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2019.01.006 · Cited by 9
Human induced pluripotent stem cell-derived cardiomyocytes for disease modeling and drug discovery
Moriwaki, T., Tani, H., & Tohyama, S. (2025) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2025.1687840 · Cited by 9
Alternative splicing dynamics during human cardiac development in vivo and in vitro
Gomes-Silva, B., Furtado, M., Ribeiro, M., Martins, S., Carvalho, T., Ventura-Gomes, A., Maatz, H., Parakkat, P., Crocini, C., Gotthardt, M., et al. (2026) · Stem Cell Reports · doi:10.1016/j.stemcr.2025.102757 · Cited by 8
Searching for new cardiovascular drugs: towards improved systems for drug screening?
Silvester, N. C., & George, C. H. (2011) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2011.625652 · Cited by 8
Chemical genetics and its potential in cardiac stem cell therapy
Vieira, J. M., & Riley, P. R. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01928.x · Cited by 9
Maury, Y., Gauthier, M., Peschanski, M., & Martinat, C. (2011) · médecine/sciences · doi:10.1051/medsci/2011274023 · Cited by 8
Wegener, M., Bader, A., & Giri, S. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.02.010 · Cited by 8
Prospect of Induced Pluripotent Stem Cell Genetic Repair to Cure Genetic Diseases
Pawitan, J. A. (2012) · Stem Cells International · doi:10.1155/2012/498197 · Cited by 9
Wei, H., Wu, J., & Liu, Z. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7362-0_2 · Cited by 9
Wehbe, Z., Ghanjati, F., & Flotho, C. (2021) · Cells · doi:10.3390/cells10092335 · Cited by 8
Penttinen, K., Prajapati, C., Shah, D. A., Rajan, D. K., Cherian, R. M., Swan, H., & Aalto‐Setälä, K. (2023) · BMC Cardiovascular Disorders · doi:10.1186/s12872-023-03234-7 · Cited by 8
Maturation of Stem cell-derived Human Heart Tissue By Mimicking Fetal Heart Rate
Nunes, S. S., Miklas, J. W., & Radisic, M. (2013) · Future Cardiology · doi:10.2217/fca.13.71 · Cited by 8
New iPSC for old long QT syndrome modeling: Putting the evidence into perspective
Li, G., Cheng, G., Wu, J., Ma, S., & Sun, C. (2013) · Experimental Biology and Medicine · doi:10.1177/1535370213514000 · Cited by 8
Metadata
- Authors
- Moretti, A., Bellin, M., Welling, A., Jung, C. B., Lam, J. T., Bott-Flügel, L., Dorn, T., Goedel, A., Höhnke, C., Hofmann, F., Seyfarth, M., Sinnecker, D., Schömig, A., & Laugwitz, K.-L.
- Affiliations
- TUM Klinikum (DE)
- Deutsches Herzzentrum München (DE)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2010-10-07
- Volume
- 363
- Issue
- 15
- Pages
- 1397-1409
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2104996733
- Cited by
- 1,251
- References
- 40
- Citations by year
- 2026: 26 · 2025: 26 · 2024: 43 · 2023: 49 · 2022: 51 · 2021: 79 · 2020: 56 · 2019: 69 · 2018: 69 · 2017: 89 · 2016: 90 · 2015: 111 · 2014: 90 · 2013: 116 · 2012: 143
- FWCI
- 88.47
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Keywords
- LQT1, KCNQ1, induced pluripotent stem cells, patient-specific disease models, cardiomyocyte differentiation, action potential prolongation, delayed rectifier potassium current, beta-adrenergic blockade, sudden cardiac death, ventricular repolarization
- MeSH terms
- Kruppel-Like Factor 4, Action Potentials, Adrenergic beta-Antagonists, Adult, Aged, Cardiotonic Agents, Child, Female, Fibroblasts, Humans, Isoproterenol, Male, Pedigree, Phenotype, Potassium Channels, Gene Expression, Mutation, Missense, Reverse Transcriptase Polymerase Chain Reaction, Potassium Channel Blockers, Romano-Ward Syndrome, Myocytes, Cardiac, KCNQ1 Potassium Channel, Induced Pluripotent Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.